Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6826)
All Articles published online
|
Mar 21, 2012 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nagarajan P, Mahesh Kumar MJ, Venkatesan R, Majundar SS, Juyal RC. Genetically modified mouse models for the study of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18(11): 1141-1153 [PMID: 22468076 DOI: 10.3748/wjg.v18.i11.1141] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v18/i11/1141.htm |
| Number | Citing Articles |
| 1 |
Elika Safar Zadeh, Andreea O. Lungu, Elaine K. Cochran, Rebecca J. Brown, Marc G. Ghany, Theo Heller, David E. Kleiner, Phillip Gorden. The liver diseases of lipodystrophy: The long-term effect of leptin treatment. Journal of Hepatology 2013; 59(1): 131 doi: 10.1016/j.jhep.2013.02.007
|
| 2 |
Nisreen Soufi, Angela M. Hall, Zhouji Chen, Jun Yoshino, Sara L. Collier, James C. Mathews, Elizabeth M. Brunt, Carolyn J. Albert, Mark J. Graham, David A. Ford, Brian N. Finck. Inhibiting Monoacylglycerol Acyltransferase 1 Ameliorates Hepatic Metabolic Abnormalities but Not Inflammation and Injury in Mice. Journal of Biological Chemistry 2014; 289(43): 30177 doi: 10.1074/jbc.M114.595850
|
| 3 |
Liza Dewyse, Hendrik Reynaert, Leo A. van Grunsven. Best Practices and Progress in Precision-Cut Liver Slice Cultures. International Journal of Molecular Sciences 2021; 22(13): 7137 doi: 10.3390/ijms22137137
|
| 4 |
Mikheil Gogiashvili, Karolina Edlund, Kathrin Gianmoena, Rosemarie Marchan, Alexander Brik, Jan T. Andersson, Jörg Lambert, Katrin Madjar, Birte Hellwig, Jörg Rahnenführer, Jan G. Hengstler, Roland Hergenröder, Cristina Cadenas. Metabolic profiling of ob/ob mouse fatty liver using HR-MAS 1H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathway. Analytical and Bioanalytical Chemistry 2017; 409(6): 1591 doi: 10.1007/s00216-016-0100-1
|
| 5 |
Melina Ribeiro Fernandes, Priscila Silva Figueiredo, Karoline Silva Rezende, Karine de Cássia Freitas, Priscila Aiko Hiane, Rita de Cássia Avellaneda Guimarães. Experimental Animal Models of Human Diseases - An Effective Therapeutic Strategy. 2018; doi: 10.5772/intechopen.72707
|
| 6 |
Dimitrios G Bouzianas, Stella D Bouziana, Apostolos I Hatzitolios. Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids. Nutrition Reviews 2013; 71(11): 753 doi: 10.1111/nure.12073
|
| 7 |
Beichu Guo, Zihai Li. Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases. Frontiers in Genetics 2014; 5 doi: 10.3389/fgene.2014.00242
|
| 8 |
Christoph G Dietrich, Oliver Götze, Andreas Geier. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World Journal of Gastroenterology 2016; 22(1): 72-88 doi: 10.3748/wjg.v22.i1.72
|
| 9 |
Shailendra Arindkar, Jashdeep Bhattacharjee, Jerald Mahesh Kumar, Barun Das, Pramod Upadhyay, Shajahan Asif, Ramesh C Juyal, Subeer S Majumdar, Nagarajan Perumal. Antigen peptide transporter 1 is involved in the development of fructose‐induced hepatic steatosis in mice. Journal of Gastroenterology and Hepatology 2013; 28(8): 1403 doi: 10.1111/jgh.12186
|
| 10 |
Boushra Bathish, Holly Robertson, John F. Dillon, Albena T. Dinkova-Kostova, John D. Hayes. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2. Free Radical Biology and Medicine 2022; 188: 221 doi: 10.1016/j.freeradbiomed.2022.06.226
|
| 11 |
Jesse D. Riordan, Joseph H. Nadeau. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. Mammalian Genome 2014; 25(9-10): 473 doi: 10.1007/s00335-014-9521-3
|
| 12 |
Tong-shuo Zhang, Hua-lei Qin, Tong Wang, Hai-tao Li, Hai Li, Shi-hai Xia, Xiao-hui Xiang. Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review. SpringerPlus 2015; 4(1) doi: 10.1186/s40064-015-1542-1
|
| 13 |
Manoj Amrutkar, Emmelie Cansby, Esther Nuñez‐Durán, Carlo Pirazzi, Marcus Ståhlman, Elin Stenfeldt, Ulf Smith, Jan Borén, Margit Mahlapuu. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH. The FASEB Journal 2015; 29(4): 1564 doi: 10.1096/fj.14-264937
|
| 14 |
Ivanna Carolina Golfetto Miskiewicz, Hyen Chung Cho, Ji In Lee, Jihye Lee, Yenna Lee, Yun Kyung Lee, Sung Hee Choi. Effect of atorvastatin on lipoxygenase pathway‐related gene expression in an in vitro model of lipid accumulation in hepatocytes. FEBS Open Bio 2023; 13(4): 606 doi: 10.1002/2211-5463.13552
|
| 15 |
Tsutomu Wada, Yusuke Miyashita, Motohiro Sasaki, Yusuke Aruga, Yuto Nakamura, Yoko Ishii, Masakiyo Sasahara, Keizo Kanasaki, Munehiro Kitada, Daisuke Koya, Hitoshi Shimano, Hiroshi Tsuneki, Toshiyasu Sasaoka. Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet. American Journal of Physiology-Endocrinology and Metabolism 2013; 305(11): E1415 doi: 10.1152/ajpendo.00419.2013
|
| 16 |
Ravirajsinh Jadeja, Ranjitsinh V. Devkar, Srinivas Nammi. Herbal Medicines for the Treatment of Nonalcoholic Steatohepatitis: Current Scenario and Future Prospects. Evidence-Based Complementary and Alternative Medicine 2014; 2014: 1 doi: 10.1155/2014/648308
|
| 17 |
Yoshitaka Kondo, Akihito Ishigami. Involvement of senescence marker protein‐30 in glucose metabolism disorder and non‐alcoholic fatty liver disease. Geriatrics & Gerontology International 2016; 16(S1): 4 doi: 10.1111/ggi.12722
|
| 18 |
Marica Cariello, Elena Piccinin, Antonio Moschetta. Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH. Cellular and Molecular Gastroenterology and Hepatology 2021; 11(5): 1519 doi: 10.1016/j.jcmgh.2021.01.012
|
| 19 |
JINKYUNG CHO, SHINUK KIM, SHINHO LEE, HYUNSIK KANG. Effect of Training Intensity on Nonalcoholic Fatty Liver Disease. Medicine & Science in Sports & Exercise 2015; 47(8): 1624 doi: 10.1249/MSS.0000000000000595
|
| 20 |
Hayato Nakagawa. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis. World Journal of Hepatology 2015; 7(17): 2110-2118 doi: 10.4254/wjh.v7.i17.2110
|
| 21 |
Soraya Hölper, Hendrik Nolte, Eva Bober, Thomas Braun, Marcus Krüger. Dissection of metabolic pathways in the Db/Db mouse model by integrative proteome and acetylome analysis. Molecular BioSystems 2015; 11(3): 908 doi: 10.1039/C4MB00490F
|
| 22 |
Jinping Gan, Brad Bolon, Terry Van Vleet, Charles Wood. Haschek and Rousseaux's Handbook of Toxicologic Pathology. 2022; : 925 doi: 10.1016/B978-0-12-821044-4.00005-4
|
| 23 |
Mariana Luisa Verdelho Moutinho Machado, Anna Mae Diehl. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; : 121 doi: 10.1007/978-3-319-20538-0_6
|
| 24 |
Yoshinori Marunaka. The Proposal of Molecular Mechanisms of Weak Organic Acids Intake-Induced Improvement of Insulin Resistance in Diabetes Mellitus via Elevation of Interstitial Fluid pH. International Journal of Molecular Sciences 2018; 19(10): 3244 doi: 10.3390/ijms19103244
|
| 25 |
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
|
| 26 |
Yoichi Asaoka, Shuji Terai, Isao Sakaida, Hiroshi Nishina. The expanding role of fish models in understanding non-alcoholic fatty liver disease. Disease Models & Mechanisms 2013; doi: 10.1242/dmm.011981
|
| 27 |
Hong Xu, Yang Zhou, Yongxia Liu, Jian Ping, Qiyang Shou, Fangming Chen, Ru Ruo. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis. Journal of Endocrinology 2016; 229(2): 133 doi: 10.1530/JOE-15-0409
|
| 28 |
D. T. Reid, B. Eksteen. Murine models provide insight to the development of non-alcoholic fatty liver disease. Nutrition Research Reviews 2015; 28(2): 133 doi: 10.1017/S0954422415000128
|
| 29 |
Alfredo Smiriglia, Nicla Lorito, Marina Serra, Andrea Perra, Andrea Morandi, Marta Anna Kowalik. Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma. iScience 2023; 26(12): 108363 doi: 10.1016/j.isci.2023.108363
|
| 30 |
Xiang‐lan Wei, Xiao‐qing Chen, Ru‐tang Fang, Xiao‐yan Sun, Chang‐sheng Zhu, Jie Yang, Xin Xue, Qiang Wang. Preventive Effects of Flavonoid Extracts from Ilex hainanensisMerr. on Rats with Hepatic Steatosis Induced by a High‐Fat Diet. Drug Development Research 2012; 73(6): 308 doi: 10.1002/ddr.21014
|
| 31 |
Rajani Kandhi, Bhavesh Variya, Sheela Ramanathan, Subburaj Ilangumaran. An improved method for isolation and flow cytometric characterization of intrahepatic leukocytes from fatty and fibrotic liver tissues. The Anatomical Record 2023; 306(5): 1011 doi: 10.1002/ar.25039
|
| 32 |
Darya A. Pon’kina, Sergey O. Kuranov, Mariya K. Marenina, Yulia V. Meshkova, Nataliya A. Zhukova, Mikhail V. Khvostov, Olga A. Luzina, Tatiana G. Tolstikova, Nariman F. Salakhutdinov. Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies. Pharmaceutics 2023; 15(6): 1670 doi: 10.3390/pharmaceutics15061670
|
| 33 |
Sunaina Gautam, C.G. Agarwal, Monisha Banerjee. Study of CI962235 (Ins1361A), rs3212018 (16 bp del) and rs1049673 (G>C) CD36 Gene Polymorphisms in T2DM Patients of North India. Journal of Medical Sciences 2013; 13(6): 439 doi: 10.3923/jms.2013.439.445
|
| 34 |
Dany Perocheau, Sonam Gurung, Loukia Touramanidou, Claire Duff, Garima Sharma, Neil Sebire, Patrick F Finn, Alex Cavedon, Summar Siddiqui, Lisa Rice, Paolo G.V. Martini, Andrea Frassetto, Julien Baruteau. Ex vivo precision-cut liver slices model disease phenotype and monitor therapeutic response for liver monogenic diseases. F1000Research 2024; 12: 1580 doi: 10.12688/f1000research.142014.2
|
| 35 |
R. E. Patterson, A. S. Kirpich, J. P. Koelmel, S. Kalavalapalli, A. M. Morse, K. Cusi, N. E. Sunny, L. M. McIntyre, T. J. Garrett, R. A. Yost. Improved experimental data processing for UHPLC–HRMS/MS lipidomics applied to nonalcoholic fatty liver disease. Metabolomics 2017; 13(11) doi: 10.1007/s11306-017-1280-1
|
| 36 |
Lanuza A.P. Faccioli, Marlon Lemos Dias, Bruno Andrade Paranhos, Regina Coeli dos Santos Goldenberg. Liver cirrhosis: An overview of experimental models in rodents. Life Sciences 2022; 301: 120615 doi: 10.1016/j.lfs.2022.120615
|
| 37 |
Jake P. Mann, Robert K. Semple, Matthew J. Armstrong. How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?. Frontiers in Endocrinology 2016; 7 doi: 10.3389/fendo.2016.00145
|
| 38 |
Yao Zhao, Yingjie Yu, Hong Li, Mingying Li, Dongran Zhang, Dandan Guo, Xiaohui Yu, Ce Lu, Hui Wang. The Association between Metabolic Syndrome and Biochemical Markers in Beijing Adolescents. International Journal of Environmental Research and Public Health 2019; 16(22): 4557 doi: 10.3390/ijerph16224557
|
| 39 |
Rhema Khairnar, Md Asrarul Islam, Joshua Fleishman, Sunil Kumar. Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics. Life Sciences 2023; 312: 121185 doi: 10.1016/j.lfs.2022.121185
|
| 40 |
Darkiane Fernandes Ferreira, Jarlei Fiamoncini, Iryna Hirata Prist, Suely Kubo Ariga, Heraldo Possolo de Souza, Thais Martins de Lima. Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2015; 1851(10): 1353 doi: 10.1016/j.bbalip.2015.07.002
|
| 41 |
Sebastian Martinez-Lopez, Enrique Angel-Gomis, Elisabet Sanchez-Ardid, Alberto Pastor-Campos, Joanna Picó, Isabel Gomez-Hurtado. The 3Rs in Experimental Liver Disease. Animals 2023; 13(14): 2357 doi: 10.3390/ani13142357
|
| 42 |
Gene P. Ables. Update on Ppar and Nonalcoholic Fatty Liver Disease. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/912351
|
| 43 |
Jashdeep Bhattacharjee, Jerald Mahesh Kumar, Shailendra Arindkar, Barun Das, Upadhyay Pramod, Ramesh C. Juyal, Subeer S. Majumdar, Perumal Nagarajan. Role of immunodeficient animal models in the development of fructose induced NAFLD. The Journal of Nutritional Biochemistry 2014; 25(2): 219 doi: 10.1016/j.jnutbio.2013.10.010
|
| 44 |
Yoshihisa Takahashi, Yurie Soejima, Toshio Fukusato. Integrative Weight Management. 2014; : 61 doi: 10.1007/978-1-4939-0548-5_6
|
| 45 |
Yan Liu, Christoph Meyer, Chengfu Xu, Honglei Weng, Claus Hellerbrand, Peter ten Dijke, Steven Dooley. Animal models of chronic liver diseases. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 304(5): G449 doi: 10.1152/ajpgi.00199.2012
|
| 46 |
Laura Vera‐Ramirez, Patricia Pérez‐Lopez, Alfonso Varela‐Lopez, MCarmen Ramirez‐Tortosa, Maurizio Battino, José L. Quiles. Curcumin and liver disease. BioFactors 2013; 39(1): 88 doi: 10.1002/biof.1057
|
| 47 |
Theodore Karatzas, Nikolaos Sikalias, Dimitrios Mantas, Apostolos Papalois, Konstantinos Alexiou, Lamprini Mountzalia, Gregory Kouraklis. Histopathological changes and onset of severe hepatic steatosis in rats fed a choline‑free diet. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6385
|
| 48 |
Kazuo Nakamoto, Shogo Tokuyama. Involvement of the Free Fatty Acid Receptor GPR120/FFAR4 in the Development of Nonalcoholic Steatohepatitis. YAKUGAKU ZASSHI 2019; 139(9): 1169 doi: 10.1248/yakushi.19-00011-4
|
| 49 |
Brian J. DeBosch, Zhouji Chen, Jessica L. Saben, Brian N. Finck, Kelle H. Moley. Glucose Transporter 8 (GLUT8) Mediates Fructose-induced de Novo Lipogenesis and Macrosteatosis. Journal of Biological Chemistry 2014; 289(16): 10989 doi: 10.1074/jbc.M113.527002
|
| 50 |
Bregje Van De Wier, Ger H. Koek, Aalt Bast, Guido R. M. M. Haenen. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. Critical Reviews in Food Science and Nutrition 2017; 57(4): 834 doi: 10.1080/10408398.2014.952399
|
| 51 |
Dany Perocheau, Sonam Gurung, Loukia Touramanidou, Claire Duff, Garima Sharma, Neil Sebire, Patrick F Finn, Alex Cavedon, Summar Siddiqui, Lisa Rice, Paolo G.V. Martini, Andrea Frassetto, Julien Baruteau. Ex vivo precision-cut liver slices model disease phenotype and monitor therapeutic response for liver monogenic diseases. F1000Research 2023; 12: 1580 doi: 10.12688/f1000research.142014.1
|
| 52 |
Sofia Tsouka, Pavitra Kumar, Patcharamon Seubnooch, Katrin Freiburghaus, Marie St-Pierre, Jean-François Dufour, Mojgan Masoodi. Transcriptomics-driven metabolic pathway analysis reveals similar alterations in lipid metabolism in mouse MASH model and human. Communications Medicine 2024; 4(1) doi: 10.1038/s43856-024-00465-3
|
| 53 |
Charlotte J. Green, Camilla Pramfalk, Karl J. Morten, Leanne Hodson. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations. American Journal of Physiology-Endocrinology and Metabolism 2015; 308(1): E1 doi: 10.1152/ajpendo.00192.2014
|
| 54 |
Mark D. DeBoer, R. Constance Wiener, Barrett H. Barnes, Matthew J. Gurka. Ethnic Differences in the Link Between Insulin Resistance and Elevated ALT. Pediatrics 2013; 132(3): e718 doi: 10.1542/peds.2012-3584
|